ATE223428T1 - Nukleoside und nukleotide mit vergrösserten ringen - Google Patents

Nukleoside und nukleotide mit vergrösserten ringen

Info

Publication number
ATE223428T1
ATE223428T1 AT94929358T AT94929358T ATE223428T1 AT E223428 T1 ATE223428 T1 AT E223428T1 AT 94929358 T AT94929358 T AT 94929358T AT 94929358 T AT94929358 T AT 94929358T AT E223428 T1 ATE223428 T1 AT E223428T1
Authority
AT
Austria
Prior art keywords
compositions
nucleosides
nucleotides
purine
ring
Prior art date
Application number
AT94929358T
Other languages
English (en)
Original Assignee
Nabi
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabi, Univ Maryland filed Critical Nabi
Application granted granted Critical
Publication of ATE223428T1 publication Critical patent/ATE223428T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT94929358T 1993-09-29 1994-09-29 Nukleoside und nukleotide mit vergrösserten ringen ATE223428T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12821293A 1993-09-29 1993-09-29
PCT/US1994/010905 WO1995009175A1 (en) 1993-09-29 1994-09-29 Ring-expanded nucleosides and nucleotides

Publications (1)

Publication Number Publication Date
ATE223428T1 true ATE223428T1 (de) 2002-09-15

Family

ID=22434211

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02001587T ATE334137T1 (de) 1993-09-29 1994-09-29 Ringerweiterte nukleoside und nukleotide
AT94929358T ATE223428T1 (de) 1993-09-29 1994-09-29 Nukleoside und nukleotide mit vergrösserten ringen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02001587T ATE334137T1 (de) 1993-09-29 1994-09-29 Ringerweiterte nukleoside und nukleotide

Country Status (9)

Country Link
EP (2) EP0724587B8 (de)
AT (2) ATE334137T1 (de)
AU (1) AU7844594A (de)
CA (1) CA2173116C (de)
DE (2) DE69431304T2 (de)
DK (2) DK1227103T3 (de)
ES (2) ES2182847T3 (de)
PT (2) PT724587E (de)
WO (1) WO1995009175A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094766B1 (en) 1995-06-06 2006-08-22 Trustees Of Boston University Use of locally applied DNA fragments
US5955059A (en) * 1995-06-06 1999-09-21 Trustees Of Boston University Use of locally applied DNA fragments
US6147056A (en) * 1995-06-06 2000-11-14 Trustees Of Boston University Use of locally applied DNA fragments
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
AU2001251115A1 (en) 2000-03-31 2001-10-15 Trustees Of Boston University Use of locally applied dna fragments
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US10190162B2 (en) 2014-10-23 2019-01-29 Complete Genomics, Inc. Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60992B2 (ja) * 1977-03-15 1985-01-11 財団法人微生物化学研究会 コホルマイシンおよび関連物質の分離法
US4163839A (en) * 1977-12-09 1979-08-07 Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai Isocoformycin and a process for the production thereof
US4935505A (en) * 1983-05-03 1990-06-19 Townsend Leroy B Novel azolo [1,3] diazepine-5-ol compounds and their uses
US4713372A (en) * 1984-03-16 1987-12-15 Warner-Lambert Company 2-chloropentostatin compound having adenosine diaminase inhibitory activity
IL108524A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Imidazodiazepine analogs

Also Published As

Publication number Publication date
ATE334137T1 (de) 2006-08-15
ES2182847T3 (es) 2003-03-16
DE69434805D1 (de) 2006-09-07
DE69431304T2 (de) 2003-05-15
DK1227103T3 (da) 2006-11-27
EP0724587A4 (de) 1996-12-27
CA2173116C (en) 2006-02-28
DK0724587T3 (da) 2003-01-06
EP0724587B8 (de) 2003-01-29
EP1227103A3 (de) 2002-10-16
EP1227103B1 (de) 2006-07-26
EP0724587A1 (de) 1996-08-07
WO1995009175A1 (en) 1995-04-06
DE69434805T2 (de) 2007-02-22
AU7844594A (en) 1995-04-18
EP1227103A2 (de) 2002-07-31
PT1227103E (pt) 2006-12-29
DE69431304D1 (de) 2002-10-10
PT724587E (pt) 2003-01-31
EP0724587B1 (de) 2002-09-04
ES2269528T3 (es) 2007-04-01
CA2173116A1 (en) 1995-04-06

Similar Documents

Publication Publication Date Title
IL101836A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
MY109796A (en) 1,3-oxathiolane nucleoside analogues.
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
IL101144A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogue and derivatives thereof for the treatment of hepatitis b virus infections
RU93043875A (ru) 1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-5-фторцитозин и способ лечения
DK224286A (da) 2',3'-dideoxy-nucleosider
MD1838G2 (ro) Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
DE69431304T2 (de) Nukleoside und nukleotide mit vergrösserten ringen
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
AU2003288869A1 (en) PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
IE893080L (en) Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives
CA2086756A1 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
MY137298A (en) Therapeutic nucleosides
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
EP0459176A3 (en) Oligophosphates with antiviral activity
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
RU93058540A (ru) Производные 2-гидроксиметил-5-/5-фторцитозин-1-ил/-1,3-оксатиолан, фармкомпозиция, способы его получения, применение, способы лечения
MY103900A (en) 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0724587

Country of ref document: EP

REN Ceased due to non-payment of the annual fee